As the SOCS1 gene repression mainly occurs via CpG methylation in diverse cancers, demethylating agents such as 5-azacytidine and decitabine could be potentially useful to restore regulated SOCS1 expression (41, 143). This evidence concerns the gene SOCS1 and cancer.